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Edited by Hans-Dieter KlenkAbstract Baculoviruses are orally infectious to insects and con-
sidered to be natural insecticides. To enhance their speed-of-kill
these viruses were engineered to express arthropod neurotoxins
under the control of various strong promoters. Although this
strategy proved to be eﬃcient, it raised recently concerns about
safety. We analyzed the speed-of-kill and safety of Autographa
californica multiple nucleopolyhedrovirus expressing the insecti-
cidal scorpion neurotoxin AaIT and found that the mortality of
Helicoverpa armigera larvae was enhanced signiﬁcantly when
the expression was controlled by the baculovirus delayed-early
promoter 39K rather than the very late promoter p10. This
improvement was also reﬂected in better protection of cotton
leaves on which these insects were fed. Using lacZ as a sensitive
reporter we also found that expression driven by the 39K
promoter was detected in insect but not in mammalian cells.
These results imply that by selection of an appropriate viral
promoter, engineered baculoviruses may comply with the high
standard biosafety requirements from a genetically modiﬁed
organism (GMO). Our results provide further support for the
potential use of engineered baculoviruses in insect pest control
in a safely manner.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Baculoviruses are a family of arthropod DNA viruses path-
ogenic mainly to insects. They are classiﬁed in two genera, the
Nucleopolyhedroviruses (NPV) and the Granuloviruses (GV) [1].
Various wild strains of baculoviruses have been developed and
utilized to control insect pests [2]. Among NPVs Helicoverpa
zea and H. armigera NPVs were utilized to control Helicoverpa
and Heliothis pests in Australia, China, India, and USA, while
Spodoptera NPVs were utilized in Brazil, Europe, and USA.
The Anticarsia gemmatalis NPV is extensively used in Brazil
to control the velvet bean caterpillar [2].Abbreviations: AcMNPV, Autographa californica multiple nucleopoly-
hedrovirus; PIB, polyhedral inclusion bodies; ET50, eﬀective time to
paralysis; MOI, multiplicity of infection
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doi:10.1016/j.febslet.2006.11.037The most investigated baculovirus is Autographa californica
nucleopolyhedrovirus (AcMNPV), which is considered the
prototype of the NPV group due to its broad host range and
amenability for growth and manipulation [3,4]. Its entire
genome was sequenced [5] and its mode of replication exten-
sively studied (for review see [1]). In an attempt to raise alter-
natives to chemical insecticides, AcMNPV was engineered to
express various anti-insect neurotoxins. This approach has
shown that the insecticidal eﬃcacy of AcMNPV could be
improved signiﬁcantly [6–11]. The earliest reports were about
toxins from a scorpion and a mite [11,12]. The anti-insect selec-
tive excitatory toxin AaIT (from the North African scorpion
Androctonus australis hector), was expressed under the control
of the very late promoter p10, and was shown to reduce the
time to death of second instar Trichoplusia ni and Heliothis
virescens larvae by 24% and 30%, respectively. The TxP-I toxin
(from the mite Pyemotes tritici), was expressed under the
control of the polyhedrin promoter, which reduced the time
to death of neonate T. ni larvae by 40%.
In an attempt to further reduce the speed-of-kill of insect
pests various combinations of viral promoters and anti-insect
selective toxins were analyzed [9,10,13,14]. These analyses have
focused on the level and time of toxin expression, which deter-
mine the overall insecticidal potency. When expression of
AaIT was driven by the immediate baculovirus early promoter
ie1, no signiﬁcant improvement was obtained over expression
driven by the strong very late promoters p10 and polyhedrin
[13]. Expression of the anti-insect toxin LqhIT1 (from the sco-
rpion Leiurus quinquestriatus hebraeus) under the control of
the early promoter p35 [9], TxP-I under the control of the early
promoter DA26 [14], and LqhIT2 (an anti-insect selective
depressant toxin from L. q. hebraeus) under the early promot-
ers ie1, lef3 and 39K [16], did not improve signiﬁcantly the
speed-of-kill. Still, expression of TxP-I under the control of
the hsp70 promoter from Drosophila melanogaster improved
the speed-of-kill of AcMNPV towards Spodoptera frugiperda
and T. ni by 13.6 and 4.7 h, respectively, compared to expre-
ssion of this toxin under the modiﬁed very-late polyhedrin
promoter PsynXIV [14].
Another important factor when use of recombinant baculo-
viruses is considered is the threat of toxin gene transfer into
non-target organisms, especially human cells. Several groups
have reported that baculovirus vectors allow eﬃcient gene
transfer in mammalian cells [16–18]. Hofmann and cowork-
ers [19] were the ﬁrst to demonstrate transcription of a
DNA sequence delivered by a recombinant baculovirus in a
human hepatoma cell line, which however required a strongblished by Elsevier B.V. All rights reserved.
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engineered under the control of the very late promoter poly-
hedrin, which is not active in a non-arthropod environment.
These ﬁndings raised the public concern about possible une-
xpected risks associated with utilization of recombinant baculo-
viruses in insect pest control [20,21].
Thus, construction of safe recombinant baculoviruses
demands careful planning of the elements introduced into their
genome, such as the promoter used for toxin expression, and
those involved in gene transfer capabilities. In this respect,
the main disadvantage of early promoters like ie-1 and consti-
tutive promoters like hsp70, which do not require viral early
gene products for their function [22–24], is their ability to drive
expression in non-permissive insect cells [23] and in mamma-
lian cells [24]. In contrast, expression driven by baculovirus
delayed-early promoters like the 39K (of the pp31 gene [5]),
is preceded by expression of other baculovirus genes like ie-1
[25]. Thus, the delayed-early promoters are less likely to drive
expression in non-permissive cells including those from
mammals [23,26].
To compare the insecticidal eﬃcacy of baculoviruses ex-
pressing a toxin under the control of a delayed-early (39K)
vs. very-late (p10 ) promoters, we have selected one of the most
studied toxins, AaIT [6,7,13]. Furthermore, by using the lacZ
reporter gene, we examined whether the 39K promoter is
eﬀective in mammalian CHO cells. Our results indicate that
the time-to-paralysis of H. armigera larvae was signiﬁcantly
shorter using vAcAaIT.39K over vAcAaIT.p10 and that the
39K promoter was practically inactive in mammalian cells.2. Materials and methods
2.1. Cell lines and viruses
Spodoptera frugiperda (Sf9) [27] and T. ni BTI-TN-5B1-4 (BTI) cells
were maintained and propagated in Grace’s insect medium, supple-
mented with yeastolate, lactalbumin, hydrolysate, and 10% heat-inac-
tivated fetal bovine serum (Biological Industries, Israel). Infection of
the cells with wild-type AcMNPV (strain E2) and recombinant viruses,
and plaque titration of virus stocks were performed in Sf9 cells, as was
described [3,9]. Mammalian CHO cells (kindly provided by Prof. R.
Stein, Tel-Aviv University) were grown in high glucose (Dulbecco’s
modiﬁed Eagle’s medium) DMEM (Sigma) supplemented with 10%
fetal calf serum. One day prior to transduction, the cells were seeded
in 6-well culture dishes (3 · 105 cell per well). After 24 h the medium
was refreshed, a virus inoculum was added (multiplicity of infection
(MOI) 20 or 100), and incubated for 1 h at 37 C. After removal of
the virus, fresh medium was added and the cultures were incubated
48 h at 37 C. When vAclacZ.hsp70 was used for infection the cells
were exposed 30 min to heat shock at 42 C 2 h after transduction.
2.2. DNA manipulations
Baculoviral DNA was prepared and analyzed according to standard
methods [3,28]. For virus constructions, the Bac-to-Bac baculovirus
expression system (Invitrogen) was employed. A plasmid bearing the
intact polyhedrin gene (pFP) was used for further construction of
baculoviruses infective per os, by excising this gene from pBlue-ph
[29] by XhoI, ﬁlled-in with Klenow, digested with EcoRI and cloned
into the Bst 1107I and EcoRI sites of pFastBac1 (Invitrogen). Con-
struction of pFP.AaIT.39K, was carried out by ﬁrst preparing
pBS.AaIT.39K, a pBluescript (Stratagene) in which the 39K promoter
(808 bp) from p39QGFP-20 [30] was cloned into the PstI and BamHI
polylinker sites, and the AaIT gene ampliﬁed by PCR from AcA-
aIT.p10 [6] was cloned into the BamHI site behind the 39K promoter.
Finally the excised AaIT cassette from pBS.AaIT.39K (digested with
XhoI, ﬁlled in by the Klenow fragment and subsequently digested with
XbaI), was inserted into pFP (digested with EcoRI, ﬁlled in by the
Klenow fragment and digested by XbaI) to obtain pFP.AaIT.39K.To construct pFP.lacZ.39K the pCMV-b (Clontech) was digested
with BamHI and a 3.6 kb fragment, bearing the lacZ gene, was ligated
into the BamHI site of pBS.39K. The 39K promoter-lacZ were excised
by XhoI and XbaI and cloned into the corresponding sites of the shut-
tle vector pFP. To obtain pFP.lacZ.hsp70, the hsp70 promoter-lacZ
was excised with BamHI from the plasmid phsp70lacZ (unpublished),
ﬁlled in with the Klenow fragment and ligated into the ﬁlled-in XbaI
site of pFP. The pFastBac-based constructs were individually trans-
ferred into Escherichia coli DH10Bac cells (Invitrogen) to generate
the corresponding recombinant bacmids. These bacmids were intr-
oduced into Sf9 insect cells by Lipofectin (Invitrogen)-mediated tran-
sfection. The recombinant viruses that budded from the cells were
collected, plaque puriﬁed and ampliﬁed as described before [9]. A
wild-type version of AcMNPV, vAcFP, was derived by introducing
pFP to the original bacmid.2.3. Toxin expression
BTI cells were infected at MOI = 10 [10] and at the indicated times
were washed with PBS and resuspended in loading buﬀer (100 mM
Tris–HCl, pH 6.8, 2% SDS, 20% glycerol, 2% b-mercaptoethanol,
5 mM DTT, 0.2% bromophenol blue) with proteinase inhibitors
(1 lM PMSF, 10 lM E-64, 2 lg/ml aprotinin). The cell extracts were
submitted to SDS–PAGE (12%), the proteins were blotted to a PVDF
membrane (NEN Life Science Products), which were immuno-deco-
rated by anti-AaIT rabbit polyclonal antiserum [8,9]. Toxin-detection
was performed by chemiluminescense after incubation with CDP-Star
(Boehringer-Mannheim, Germany) and exposure to Kodak Biomax
Light Film.2.4. Biological assays
Oral infection of H. armigera neonates (less than 12-h-old) was
performed with polyhedral inclusion bodies (PIBs) by the diet contam-
ination method [10]. Forty-eight H. armigera neonate larvae were
exposed 24 h to 7.5 · 103 PIBs/mm2 at 29.5 C to obtain 95–100%
mortality within seven days [10]. Then fresh artiﬁcial diet was added
and the larvae were returned to the incubator. Paralysis or death of
infected-larvae was monitored at 4–6 h intervals for the ﬁrst 4 days
and 10–12 h thereafter. Eﬀective time 50% (ET50) values of paralysis
or death were determined using ViStat [31]. The resulting values for
each virus were averaged and analysed by ANOVA (one-way analysis
of variance), the means were separated by LSD test (Fisher’s least sig-
niﬁcant diﬀerence) [32] and MRT test (multiple range test). The statis-
tical analysis was performed by the program Statgraph version 5.0.2.5. Leaf bioassays
Feeding assays were performed with orally-infected H. armigera
neonate larvae using the diet contamination method [9]. Control larvae
were fed with artiﬁcial diet at 29.5 C. Twenty-four hours after infec-
tion, individual cotton leaves were inserted into a 20 cm3 glass vial con-
taining 2 cm layer of 1% agar solution for water supply. One larva
previously fed with the contaminated food (or clean food in the control
treatment) was placed on each leaf and the vial was closed tightly [33].
The larvae were held at 16L:8D and 60% relative humidity in a growth
chamber at 24 C, conditions found optimal for maintenance of the
cotton leaves during the entire bioassay. After one week the leaves
were scanned (UMAX Astra 3400, 300 dpi) and the leaf area con-
sumed by the larvae was calculated using PhotoShop program version
5.0. The experiment was performed in duplicates, 15–22 leaves per
treatment. Statgraph version 5.0 [32] and an included ANOVA
(one-way analysis of variance), LSD test (Fisher’s least signiﬁcant
diﬀerence) and MRT test (multiple range test) were used for statistical
analyses. Data were log transformed and the variance was analysed by
Bartlett’s test.2.6. b-Galactosidase assays
Levels of b-galactosidase were measured with o-nitrophenyl
b-D-galactopyranoside (ONPG) [28]. CHO or BTI cells were infected
with vAclacZ.39K or vAclacZ.hsp70 at MOI of 20 or 100. Cell extracts
were prepared at 48 h.p.i. Protein amounts were determined using the
Protein Assay kit (Bio-Rad). b-Galactosidase activity is expressed as
units (nmol ONPG cleaved/min/mg protein) calculated according to
published instructions [28]. In situ staining of b-galactosidase activity,
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Fig. 2. Expression of AaIT in insect cells, time-course analysis.
Extracts from BTI cells infected with the recombinant baculoviruses
were harvested at various time-points and subjected to SDS–PAGE
and immunoblot analysis. (A) vAcAaIT.39K, (B) vAcAaIT.p10. Ac
and m, mock-infected cell extracts, respectively. AaIT was detected by
anti-AaIT antiserum and chemiluminescence.
Table 1
Time–response of Helicoverpa armigera larvae infected per os with
baculoviruses expressing AaIT under the control of various regulatory
elements
Virus ET50 ± S.E.
a Slope ± S.E.
AcMNPV 92.2 ± 4.3 a 6.2 ± 0.9
vAcAaIT.p10 80.8 ± 4.6 b 5.4 ± 0.9
vAcAaIT.39K 72.0 ± 3.8 c 5.5 ± 0.8
F 7.18 1.2
P <0.01 0.3
aEﬀective time (hours post infection) to paralysis or kill 50% of H.
armigera neonate larvae infected at a LC95 dose of PIBs delivered by
diet incorporation (7500 PIBs/mm2). ET50, standard error and slope
were calculated using the ViStat program [31]. Small case letters
indicate signiﬁcant diﬀerences between treatments within the column
(P < 0.05). All assays were performed in triplicates.3. Results
3.1. Determination of toxin levels under the expression of various
promoters
The timing and relative level of AaIT expression by
AcMNPV in BTI cells was compared using the early 39K
and very late p10 promoters. In vAcAaIT.39K, the AaIT gene
was placed under the control of the 39K promoter (Fig. 1); and
in vAcAaIT.p10, AaIT was placed under the control of
promoter p10 [6]. Since the p10 promoter is most active very
late during baculovirus infection we performed a time-course
analysis of AaIT-production controlled by the 39K and p10
promoters. BTI cells were infected at MOI = 10 with vAcA-
aIT.p10 or vAcAaIT.39K and harvested at 3, 6, 9, 18 and
48 h.p.i. Subsequent immunoblots revealed that AaIT was
expressed at 9 h.p.i. in vAcAaIT.39K-infected cells and its
steady state-levels reached a peak at 18 h.p.i. (Fig. 2A). In cells
infected with vAcaIT.p10, AaIT was ﬁrst detected at 18 h.p.i.
and reached its highest level at 48 h.p.i. (Fig. 2B). As expected,
no AaIT was detected in wild type AcMNPV- or mock-
infected cell extracts (Fig. 2A and B). Thus, production of
AaIT under the 39K promoter was detected 9 h earlier com-
pared to its appearance under the control of the p10 promoter.
On the other hand, p10 was more eﬃcient than 39K when the
expression was compared at 48 h.p.i. We then examined how
these temporal diﬀerences in AaIT-expression correlated with
the time-to-paralysis of infected H. armigera larvae.
3.2. Insecticidal eﬃcacy of vAcAaIT.39K over vAcAaIT.p10
The insecticidal eﬃcacy of wild type AcMNPV, its bacmid-
derived version vAcFP, and the vAcAaIT.39K and vAcA-
aIT.p10 viral constructs were examined in neonateH. armigera
larvae fed with polyhedra. The eﬀective time to paralysis
(ET50) values for vAcAaIT.39K (8.8 h) and vAcAaIT.p10
(20.2 h) were shorter than that for wild type AcMNPV.
AcMNPV and vAcFP exhibited identical results in the bio-
assays (not shown). Thus, vAcAaIT.39K was 21.9% more
eﬀective compared to AcMNPV, while vAcAaIT.p10 was only
12.4% more eﬀective (Table 1).
3.3. Leaf assay
To examine the correlation between changes in the insecticidal
eﬃcacy determined on insect pest neonates and the actual in vivo
protection eﬀect of the engineered baculoviruses we determined
the extent by which vAcAaIT.39K and vAcAaIT.p10 reduce
plant damage caused by lepidopteran larvae. H. armigera
neonates were infected with vAcAaIT.39K, vAcAaIT.p10, and
wild type AcMNPV and placed on cotton leaves for one weekFig. 1. Construction of AcMNPV for expression of the AaIT scorpion toxin
under the control of the 39K promoter (see Section 2).under controlled conditions. Then the surface of the leaves
was scanned as described in Section 2. The results clearly indi-
cated that larvae infected with vAcAaIT.39K consumed 75%
and 81% less foliage of cotton leaves compared to larvae infected
with vAcAaIT.p10 and AcMNPV, respectively (F = 96.82;
df = 3,150; P> 0.01) and 99% less than healthy control larvae
(Fig. 3 and Table 2).
3.4. Transduction- and infection-mediated expression of the lacZ
gene
We investigated the potency of the 39K viral promoter in
mammalian cells by placing the lacZ reporter under the
control of either the 39K promoter or the hsp70 heat shock
promoter from Drosophila. The expression of b-galactosidase
in CHO mammalian cell line was compared to that in the
BTI insect cell line used as a reference. The CHO cells were
transduced with two viral constructs, vAclacZ.39K and. The exogenous DNA sequences were cloned in the polyhedrin locus
Fig. 3. Leaf assay. Cotton leaves were exposed to H. armigera neonate
larvae infected with either of AcMNPV, vAcAaIT.p10, and vAcA-
aIT.39K, or mock-infected larvae as a control. Quantitative results are
presented in Table 2.
Table 2
Leaf area consumed by H. armigera larvae orally fed with baculovi-
ruses expressing AaIT under the 39K and p10-promoters
Viral treatment Mean leaf area consumed (mm2) ± S.E.
vAcAaIT.39K 1.39 ± 0.54
vAcAaIT.p10 5.66 ± 1.02
AcMNPV 7.31 ± 1.49



















































Fig. 4. Expression of lacZ driven by the 39K or the hsp70 promoters in CHO
baculoviruses bearing the lacZ gene at MOI of 20 or 100. The cells were sta
Table 3
Expression of b-galactosidase in mammalian and insect cells trans-









vAclacZ.39K 39K 20 0.01 41.67
vAclacZ.39K 39K 100 0.01 ND
vAclacZ.hsp70 hsp70 20 0.02 218.76
vAclacZ.hsp70 hsp70 100 0.31 ND
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respectively. BTI insect cells were infected with these con-
structs at MOI = 20. The cells were stained with X-gal to
detect b-galactosidase production (Fig. 4). Whereas no b-
galactosidase could be detected in the mock infected- or vAc-
lacZ.39K-transduced-CHO cells (Fig. 4F and E, respectively
and Table 3), the proportion of stained CHO cells increased
in a dose-dependent manner according to the MOI of the
transducing- vAclacZ.hsp70 vector (Fig. 4D and G, and Table
3). In BTI cells the intensity of staining was much stronger for
vAclacZ.hsp70 compared to cells infected with vAclacZ.39K,
which reﬂected the diﬀerence in promoter strength (Fig. 4A
and B, respectively). Mock-infected BTI cells did not reveal
any detectable amount of b-galactosidase (Fig. 4C).
In CHO mammalian cells expression of b-galactosidase
under the control of the hsp70 promoter was weak compared
to its expression in BTI cells (Table 3 and Fig. 4). Expression
of b-galactosidase under the control of the 39K promoter,
which was prominent in BTI cells, was undetectable in CHO
cells (Table 3 and Fig. 4). The value of 0.01 (U/mg) determined
for the CHO cells was in the range of the control (mock-Mammalian cells
100 MOI 20
G
and BTI cells. 3 · 105 cells were infected with the indicated recombinant
ined in situ with X-gal 48 h.p.i. to detect b-galactosidase activity.
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promoter is practically unable to drive expression in CHO
mammalian cells.4. Discussion
Engineering of baculoviruses, particularly AcMNPV, with
toxin genes has been long proven to increase their insecticidal
eﬃcacy and better protect crops against insect pests [34]. The
two main concerns in this respect are the speed-of-kill and
the safety of use. The safety concern includes infectivity
towards non-target organisms and the issue of toxin speciﬁcity,
but also considers the risk of gene transfer into non-target
organisms. The high speciﬁcity (narrow host range) of baculo-
viruses for Lepidopteran hosts together with the high selectiv-
ity of the toxin to insects provides safety at two-levels, as was
shown for non-target organisms, such as insect predators,
parasitoids, and beneﬁcial insects [2,34]. It has also been
reported that wild-type baculoviruses survive better than
recombinant viruses that kill faster their target due to a higher
yield of polyhedra produced and available for spread the infec-
tion through the larval population [26]. This phenomenon also
reduces the potential risk of toxin gene ‘jumping’/shuﬄing via
homologous recombination between the DNA of the incoming
recombinant virus and an endogenous baculovirus, which may
exist in an insect population, because it would not provide any
selective advantage [34,35].
The implementation of recombinant baculoviruses has
raised recently a new concern when it was discovered that
baculoviruses are able to enter and express certain genes in
mammalian cells [16]. As the risks associated with their putative
use in insect pest control increase, this phenomenon has ironically
gained momentum in mammalian gene therapy because of the
potential use of these viruses as transducing vectors [17]. Thus
far, the most eﬃcient baculovirus constructs developed for
agricultural applications were those engineered to express
anti-insect selective scorpion toxins under the control of the
very-late viral promoters p10 and polyhedrin [6,7,9]. These
promoters were responsible for selective toxin expression in
permissive-insect cells or animals because they required bacu-
lovirus replication in order to be active [23]. Thus, expression
of toxins in insect pests was seemingly safe [34]. However,
the many eﬀorts to improve the insecticidal eﬃcacy and match
the results obtained with chemical insecticides led to the devel-
opment of recombinant baculoviruses in which expression of
anti-insect toxins was driven by immediate early baculovirus
promoters, e.g. ie1, or the heat shock promoter hsp70 from
Drosophila [13,15,36]. The caveat in these experiments was
the lack of speciﬁcity for insects as both promoters were also
functional in mammalian cells [24]. As anticipated from the
ﬁndings of Gong and Guarino [25], b-galactosidase expression
driven by the 39K promoter was not detected in mammalian
cells (Fig. 4), which highlighted the important aspect of safety
in using such a baculovirus promoter. The sharp diﬀerence of
the 39K potency in insect and mammalian cells accentuated
when a 5-fold higher virus inoculum was applied in mamma-
lian cells (Table 3 and Fig. 4).
In conclusion, the recombinant baculovirus vAcAaIT.39K
seems to be more eﬃcient than vAcAaIT.p10, and due to its
inability to express in mammalian cells provides new measures
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